Research and development in the field of covalent protein biologics; medical and scientific research in the field of cancer treatment and diagnosis; pharmaceutical research and development; research and development of pharmaceuticals and biologicals in the field of cancer therapeutics; research and development in the field of synthetic biology enabled covalent therapeutics and covalent protein drugs; research and development for the purpose of selective covalent modification of proteins; research and development in the field of oncology, namely, development of a biotechnology platform to create covalent protein biologics for treating cancer; research and development in the field of covalent protein drugs, namely, development of a platform technology for identification of small-molecule and biologic therapeutics for treating cancer and targeting tumors; conducting clinical trials for others in the field of cancer therapeutics; biotechnology testing services, namely, synthetic chemistry, recombinant protein production, bioconjugation, testing, and analysis; research and development services in the field of antibody-drug conjugates, T cells, natural killer (NK) cells, and macrophage engaging antibodies; research and development services for the purpose of antibody engineering, namely, custom design and engineering of antibodies

Class [005]
Pharmaceutical Products

Pharmaceutical products, preparations, and substances for the treatment of cancer; cancer therapeutics, namely, anti-cancer preparations; novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer and tumors; biological preparations and substances for the treatment, diagnosis, detection, and prevention of cancer; pharmaceutical products consisting of covalent protein biologics; pharmaceutical products, namely, covalent protein drugs; pharmaceuticals products consisting of synthetic biology enabled covalent protein biologics; pharmaceutical products consisting of covalent protein drugs; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Class [001]
Chemical Products

Chemical products for use in industry and science; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; antibody reagents for scientific purposes; in-vivo diagnostic reagents for scientific or research use; enzymes for scientific use; cell culture media for use in scientific research; active chemical ingredients for use in the manufacture of anti-cancer drugs; laboratory chemicals, namely, an antibody reagent used for the detection of cancerous tumors; antibodies for research use

Mark Details

Serial Number

No 97716190

Mark Type

No Service Mark

Attorney Docket Number

No 60801-TM1003

44D Filed

44D Current

44E filed

44E Current

66A Filed

66A Current

Current Basis

No Basis

Legal History

Status Date	Action Taken
09^th Jan 2024	ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
09^th Jan 2024	ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
23^rd Sep 2023	NON-FINAL ACTION WRITTEN
23^rd Sep 2023	NON-FINAL ACTION E-MAILED
23^rd Sep 2023	NOTIFICATION OF NON-FINAL ACTION E-MAILED
16^th Sep 2023	ASSIGNED TO EXAMINER
10^th Jan 2023	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16^th Dec 2022	NEW APPLICATION ENTERED

PAD-LOCK

Classification Information

Class [042]Computer & Software Services & Scientific Services

Class [005]Pharmaceutical Products

Class [001]Chemical Products